Table 2. Vaccination assumptions.

Parameter	Value	Data Sources
Relative susceptibility to infection (compared with unvaccinated)
PMP vaccine	0%–15%	[1,17,19,36,37]
PMC vaccine	0%–10%	[38,39]
Duration of protection
PMP vaccine
Age 1–4 years	1–3 years	[19,20]
Age 5+ years	3–5 years	[1,21]
PMC vaccine	10–20 years	[28,39]
Delay between administration of PMP or PMC and the establishment of immunity	2 weeks	[40]
Vaccine uptake
Routine vaccination#	80%–90%	[41]
Preventative and reactive vaccination (within 10 days)	90%–100%	[7–9]

^#Vaccine uptake for routine vaccination was assumed to be equal to the 9-mo measles coverage [41].

PMC, polyvalent meningococcal conjugate; PMP, polyvalent meningococcal polysaccharide.